The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 02, 2018
Filed:
Jul. 22, 2016
Applicant:
Abbvie Inc., North Chicago, IL (US);
Inventors:
Andrew Bogdan, Evanston, IL (US);
Warren M. Kati, Gurnee, IL (US);
Keith F. McDaniel, Wauconda, IL (US);
Chang H. Park, Wadsworth, IL (US);
George S. Sheppard, Wilmette, IL (US);
Le Wang, Vernon Hills, IL (US);
Assignee:
AbbVie Inc., North Chicago, IL (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/506 (2006.01); C07D 487/04 (2006.01); C07D 211/86 (2006.01); C07D 405/04 (2006.01); C07D 401/04 (2006.01); C07D 417/04 (2006.01); C07D 401/12 (2006.01); C07D 405/12 (2006.01); C07D 413/12 (2006.01); C07D 417/12 (2006.01); C07D 213/69 (2006.01); A61K 31/4412 (2006.01); A61K 31/4433 (2006.01); A61K 31/4439 (2006.01); A61K 31/444 (2006.01); A61K 31/4709 (2006.01); A61K 31/497 (2006.01);
U.S. Cl.
CPC ...
A61K 31/506 (2013.01); A61K 31/444 (2013.01); A61K 31/4412 (2013.01); A61K 31/4433 (2013.01); A61K 31/4439 (2013.01); A61K 31/4709 (2013.01); A61K 31/497 (2013.01); C07D 211/86 (2013.01); C07D 213/69 (2013.01); C07D 401/04 (2013.01); C07D 401/12 (2013.01); C07D 405/04 (2013.01); C07D 405/12 (2013.01); C07D 413/12 (2013.01); C07D 417/04 (2013.01); C07D 417/12 (2013.01); C07D 487/04 (2013.01);
Abstract
The present invention provides for compounds of formula (I) wherein Y, Y, R, R, R, A, A, A, and A, have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents for the treatment of diseases and conditions, including inflammatory diseases, cancer, and AIDS. Also provided are pharmaceutical compositions comprised of one or more compounds of formula (I).